Advertisement
Pfizer announced the preliminary laboratory data in a press release and it hasn’t yet undergone scientific review.The companies already are working to create an Omicron-specific vaccine in case it’s needed.
Scientists have speculated that the high jump in antibodies that comes with a third dose of Covid-19 vaccines might be enough to counter any decrease in effectiveness.
Antibody levels predict how well a vaccine may prevent infection with the coronavirus but they are just one layer of the immune system’s defenses. Pfizer said two doses of the vaccine may still induce protection against severe disease.
Related Articles
Advertisement